世界の医薬品連続製造市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV04247)
◆英語タイトル:Global Pharmaceutical Continuous Manufacturing Market Size, Status and Forecast 2020-2026
◆商品コード:QYR20NV04247
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:95
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは医薬品連続製造の世界市場について調査・分析した資料です。種類別(医薬品有効成分、生物製剤、乾燥粉末)の市場規模、用途別(製薬会社、契約製造組織)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別医薬品連続製造の競争状況、市場シェア
・世界の医薬品連続製造市場:種類別市場規模 2015年-2020年(医薬品有効成分、生物製剤、乾燥粉末)
・世界の医薬品連続製造市場:種類別市場規模予測 2021年-2026年(医薬品有効成分、生物製剤、乾燥粉末)
・世界の医薬品連続製造市場:用途別市場規模 2015年-2020年(製薬会社、契約製造組織)
・世界の医薬品連続製造市場:用途別市場規模予測 2021年-2026年(製薬会社、契約製造組織)
・北米の医薬品連続製造市場分析:米国、カナダ
・ヨーロッパの医薬品連続製造市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの医薬品連続製造市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の医薬品連続製造市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの医薬品連続製造市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Siemens、Corning Life Sciences、GEA Group、S K Biotek、Scott Equipment Company、Korsch、Continuus Pharmaceuticals、Chemtrix
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

In pharmaceutical continuous manufacturing technology, active ingredients are produced in compact, closed units, leveraging automation. Hence, it requires fewer manual interventions. Production steps carried out sequentially in a classic batch process are combined in a continuous process. All these help to bring about continued utilization of production capacity. This in turn serves to reduce fluctuations in production, improve yields, and lower costs of operation and equipment. On account of such advantages, the method is seeing fast adoption.

Market Analysis and Insights: Global Pharmaceutical Continuous Manufacturing Market
The global Pharmaceutical Continuous Manufacturing market size is projected to reach US$ 1877.1 million by 2026, from US$ 1781 million in 2020, at a CAGR of 5.0%% during 2021-2026.

Global Pharmaceutical Continuous Manufacturing Scope and Market Size
Pharmaceutical Continuous Manufacturing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pharmaceutical Continuous Manufacturing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Siemens
Corning Life Sciences
GEA Group
S K Biotek
Scott Equipment Company
Korsch
Continuus Pharmaceuticals
Chemtrix

Market segment by Type, the product can be split into
Active Pharmaceutical Ingredient
Biologics
Dry Powders
Market segment by Application, split into
Pharmaceutical Companies
Contract Manufacturing Organization

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pharmaceutical Continuous Manufacturing Revenue
1.4 Market by Type
1.4.1 Global Pharmaceutical Continuous Manufacturing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Active Pharmaceutical Ingredient
1.4.3 Biologics
1.4.4 Dry Powders
1.5 Market by Application
1.5.1 Global Pharmaceutical Continuous Manufacturing Market Share by Application: 2020 VS 2026
1.5.2 Pharmaceutical Companies
1.5.3 Contract Manufacturing Organization
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Pharmaceutical Continuous Manufacturing Market Perspective (2015-2026)
2.2 Global Pharmaceutical Continuous Manufacturing Growth Trends by Regions
2.2.1 Pharmaceutical Continuous Manufacturing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pharmaceutical Continuous Manufacturing Historic Market Share by Regions (2015-2020)
2.2.3 Pharmaceutical Continuous Manufacturing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Pharmaceutical Continuous Manufacturing Market Growth Strategy
2.3.6 Primary Interviews with Key Pharmaceutical Continuous Manufacturing Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Continuous Manufacturing Players by Market Size
3.1.1 Global Top Pharmaceutical Continuous Manufacturing Players by Revenue (2015-2020)
3.1.2 Global Pharmaceutical Continuous Manufacturing Revenue Market Share by Players (2015-2020)
3.1.3 Global Pharmaceutical Continuous Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pharmaceutical Continuous Manufacturing Market Concentration Ratio
3.2.1 Global Pharmaceutical Continuous Manufacturing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pharmaceutical Continuous Manufacturing Revenue in 2019
3.3 Pharmaceutical Continuous Manufacturing Key Players Head office and Area Served
3.4 Key Players Pharmaceutical Continuous Manufacturing Product Solution and Service
3.5 Date of Enter into Pharmaceutical Continuous Manufacturing Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Pharmaceutical Continuous Manufacturing Historic Market Size by Type (2015-2020)
4.2 Global Pharmaceutical Continuous Manufacturing Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Pharmaceutical Continuous Manufacturing Market Size by Application (2015-2020)
5.2 Global Pharmaceutical Continuous Manufacturing Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Pharmaceutical Continuous Manufacturing Market Size (2015-2020)
6.2 Pharmaceutical Continuous Manufacturing Key Players in North America (2019-2020)
6.3 North America Pharmaceutical Continuous Manufacturing Market Size by Type (2015-2020)
6.4 North America Pharmaceutical Continuous Manufacturing Market Size by Application (2015-2020)

7 Europe
7.1 Europe Pharmaceutical Continuous Manufacturing Market Size (2015-2020)
7.2 Pharmaceutical Continuous Manufacturing Key Players in Europe (2019-2020)
7.3 Europe Pharmaceutical Continuous Manufacturing Market Size by Type (2015-2020)
7.4 Europe Pharmaceutical Continuous Manufacturing Market Size by Application (2015-2020)

8 China
8.1 China Pharmaceutical Continuous Manufacturing Market Size (2015-2020)
8.2 Pharmaceutical Continuous Manufacturing Key Players in China (2019-2020)
8.3 China Pharmaceutical Continuous Manufacturing Market Size by Type (2015-2020)
8.4 China Pharmaceutical Continuous Manufacturing Market Size by Application (2015-2020)

9 Japan
9.1 Japan Pharmaceutical Continuous Manufacturing Market Size (2015-2020)
9.2 Pharmaceutical Continuous Manufacturing Key Players in Japan (2019-2020)
9.3 Japan Pharmaceutical Continuous Manufacturing Market Size by Type (2015-2020)
9.4 Japan Pharmaceutical Continuous Manufacturing Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Pharmaceutical Continuous Manufacturing Market Size (2015-2020)
10.2 Pharmaceutical Continuous Manufacturing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pharmaceutical Continuous Manufacturing Market Size by Type (2015-2020)
10.4 Southeast Asia Pharmaceutical Continuous Manufacturing Market Size by Application (2015-2020)

11 India
11.1 India Pharmaceutical Continuous Manufacturing Market Size (2015-2020)
11.2 Pharmaceutical Continuous Manufacturing Key Players in India (2019-2020)
11.3 India Pharmaceutical Continuous Manufacturing Market Size by Type (2015-2020)
11.4 India Pharmaceutical Continuous Manufacturing Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Pharmaceutical Continuous Manufacturing Market Size (2015-2020)
12.2 Pharmaceutical Continuous Manufacturing Key Players in Central & South America (2019-2020)
12.3 Central & South America Pharmaceutical Continuous Manufacturing Market Size by Type (2015-2020)
12.4 Central & South America Pharmaceutical Continuous Manufacturing Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Siemens
13.1.1 Siemens Company Details
13.1.2 Siemens Business Overview
13.1.3 Siemens Pharmaceutical Continuous Manufacturing Introduction
13.1.4 Siemens Revenue in Pharmaceutical Continuous Manufacturing Business (2015-2020))
13.1.5 Siemens Recent Development
13.2 Corning Life Sciences
13.2.1 Corning Life Sciences Company Details
13.2.2 Corning Life Sciences Business Overview
13.2.3 Corning Life Sciences Pharmaceutical Continuous Manufacturing Introduction
13.2.4 Corning Life Sciences Revenue in Pharmaceutical Continuous Manufacturing Business (2015-2020)
13.2.5 Corning Life Sciences Recent Development
13.3 GEA Group
13.3.1 GEA Group Company Details
13.3.2 GEA Group Business Overview
13.3.3 GEA Group Pharmaceutical Continuous Manufacturing Introduction
13.3.4 GEA Group Revenue in Pharmaceutical Continuous Manufacturing Business (2015-2020)
13.3.5 GEA Group Recent Development
13.4 S K Biotek
13.4.1 S K Biotek Company Details
13.4.2 S K Biotek Business Overview
13.4.3 S K Biotek Pharmaceutical Continuous Manufacturing Introduction
13.4.4 S K Biotek Revenue in Pharmaceutical Continuous Manufacturing Business (2015-2020)
13.4.5 S K Biotek Recent Development
13.5 Scott Equipment Company
13.5.1 Scott Equipment Company Company Details
13.5.2 Scott Equipment Company Business Overview
13.5.3 Scott Equipment Company Pharmaceutical Continuous Manufacturing Introduction
13.5.4 Scott Equipment Company Revenue in Pharmaceutical Continuous Manufacturing Business (2015-2020)
13.5.5 Scott Equipment Company Recent Development
13.6 Korsch
13.6.1 Korsch Company Details
13.6.2 Korsch Business Overview
13.6.3 Korsch Pharmaceutical Continuous Manufacturing Introduction
13.6.4 Korsch Revenue in Pharmaceutical Continuous Manufacturing Business (2015-2020)
13.6.5 Korsch Recent Development
13.7 Continuus Pharmaceuticals
13.7.1 Continuus Pharmaceuticals Company Details
13.7.2 Continuus Pharmaceuticals Business Overview
13.7.3 Continuus Pharmaceuticals Pharmaceutical Continuous Manufacturing Introduction
13.7.4 Continuus Pharmaceuticals Revenue in Pharmaceutical Continuous Manufacturing Business (2015-2020)
13.7.5 Continuus Pharmaceuticals Recent Development
13.8 Chemtrix
13.8.1 Chemtrix Company Details
13.8.2 Chemtrix Business Overview
13.8.3 Chemtrix Pharmaceutical Continuous Manufacturing Introduction
13.8.4 Chemtrix Revenue in Pharmaceutical Continuous Manufacturing Business (2015-2020)
13.8.5 Chemtrix Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

...

【掲載企業】

Siemens、Corning Life Sciences、GEA Group、S K Biotek、Scott Equipment Company、Korsch、Continuus Pharmaceuticals、Chemtrix

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の医薬品連続製造市場2026:インサイト・予測(Global Pharmaceutical Continuous Manufacturing Market Size, Status and Forecast 2020-2026)]についてメールでお問い合わせはこちらでお願いします。